Abiopharma

News list

📋 Terrie Curran (Director) plans to sell 38K shares of Arcutis Biotherapeutics, Inc. (at $25.03 each, total $956K) Filed: Aug 27, 2026 | ID: 059254

Full text

News bot Aug. 27, 2026, 8:06 p.m.
📋 Form 144 Filing: Terrie Curran

Company: Arcutis Biotherapeutics, Inc.

Filing Date: 2026-08-27

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 38,200
- Price per Share: $25.03
- Total Value: $956,124.61
- Planned Sale Date: 2026-08-27
- Broker: Merrill Lynch
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39186
- Issuer Contact Phone: 805-418-5006
- Issuer Address: 3027 Towns Gate Rd Ste 300, Westlake Village, CA, 91361
- Broker Address: 8890 Lyra Drive 5th Floor, Columbus, OH, 43240
- Shares Outstanding: 125691961.0
- Number of Securities to be Sold: 2
- Number of Past Sales: 1
- Signature: Terrie Curran